Biodegradable Polymer Drug-Eluting Stents: Can a Class Effect Be Assumed?

JACC Cardiovasc Interv. 2017 Mar 13;10(5):474-476. doi: 10.1016/j.jcin.2017.01.005.

Authors

Jeffrey W Moses¹, Vivian G Ng²

Affiliations

¹ Department of Internal Medicine, Division of Cardiology, Columbia University Medical Center, New York, New York. Electronic address: [email protected].
² Department of Internal Medicine, Division of Cardiology, Columbia University Medical Center, New York, New York.

PMID: 28279315
DOI: 10.1016/j.jcin.2017.01.005

No abstract available

Keywords: bioresorbable polymer stent(s); stent thrombosis.

Publication types

Editorial
Comment

MeSH terms

Drug-Eluting Stents*
Percutaneous Coronary Intervention
Polymers*
Randomized Controlled Trials as Topic
Sirolimus

Substances

Polymers
Sirolimus